Healthy Business Matters: GLP-1 Alone Are Not a Metabolic Strategy

GLP-1s are powerful.

They reduce appetite.

They lower A1C.

They drive meaningful weight loss.

For many patients, they are clinically appropriate and life-changing.

What’s controversial isn’t the drug.

It’s how employers are deploying it.

In too many health plans, GLP-1s are being used as the metabolic strategy instead of as a tool inside one. And those are not the same thing.

In this episode, Dr. Andrew White breaks down why weight loss alone does not equal metabolic durability and why employers who ignore sequencing, movement capacity, and off-ramps may be increasing long-term pharmacy exposure instead of reducing risk.

If you’re a CFO, broker, HR leader, or operator evaluating GLP-1 coverage, this episode gives you a practical framework you can use in your next renewal meeting.

What You’ll Learn

• Why GLP-1s reduce calories but don’t automatically restore movement capacity
• The difference between weight loss and metabolic resilience
• Why skeletal muscle is the real metabolic insurance policy
• The five-step sequence required for a true employer metabolic strategy
• Why most GLP-1 vendors avoid discussing discontinuation
• The blind spot almost no GLP-1 programs track: strength and muscle preservation
• Five hard questions every CFO should ask before approving coverage

The 5-Step Metabolic Strategy Framework

1. Remove inhibitors of movement
2. Restore movement capacity
3. Improve insulin sensitivity intentionally
4. Define the pharmacology off-ramp before starting
5. Reduce long-term pharmacy dependency

Because if the drug stops and the risk returns, you didn’t change the pathway you suppressed a symptom

Who This Episode Is For

• Self-funded employers
• CFOs evaluating pharmacy exposure
• Brokers navigating competitive GLP-1 pressure
• HR leaders caught between recruitment demands and long-term cost control

If you care about reducing risk instead of managing optics, this episode is for you.

About the Host

Dr. Andrew White is the Founder and CEO of AlignWell, a national MSK and metabolic risk management company working with self-funded employers to reduce long-term claims exposure by changing where care starts and how risk is sequenced.

If this episode sharpened your thinking:

Share it with a broker or CFO who needs a clearer framework

Follow/subscribe on Apple or Spotify so you don’t miss future episodes

Send topic ideas or renewal questions to [e-mail]

Healthy Business Matters is built for people who make real decisions.

Clear thinking. Better incentives. Healthier businesses.